Abstract
Parkinson disease (PD) symptoms can include motor instability, increased response time, attentional deficits, visual impairment, daytime sleepiness, and medication-exacerbated sleep attacks. 1 Because all of these factors may compromise capacity to drive, this has caused concerns over the driving safety of people with PD and has led to recent policy debate over the need for mandatory-based reevaluation of fitness to drive in those with degenerative diseases. 2 As cessation of driving can compromise independence and lead to isolation, such decisions should be informed by the best possible evidence base. Unfortunately, research findings are somewhat inconsistent, likely because of considerable variation in study methodology, and there is currently no clear overall picture of driving safety risk in PD or whether this risk is influenced by disease stage or medication use.
While narrative reviews 3, 4 have been helpful in summarizing research evidence on driving impairment, there is a pressing need for a quantitative synthesis of all available empirical data that accounts for study heterogeneity, to provide the best possible evidence for guiding driving decisions in PD. The current study is the first meta-analysis to compare individuals with PD and healthy controls (HCs) on driving performance measures from on-the-road (OTR), driving simulator, and real-life crash studies and aims to establish the following: (1) precise estimates of the magnitude of any driving impairment; (2) the influence of severity stage and medication on impairment; and (3) whether PD is linked to both poorer performance on driving assessments and an inflated real-life crash risk.
Methods
This systematic review and meta-analysis was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, 5 and followed an a priori but unpublished protocol available on request.
Eligibility criteria
Inclusion criteria were the use of (1) a group with a diagnosis of primary (idiopathic) PD, (2) a neurologically healthy control group, and (3) at least one quantitative measure of driving performance from real-world driving data, OTR tests, or driving simulator assessments.
Three types of driving assessment were included to provide a comprehensive evaluation of driving performance. Realworld, naturalistic assessment typically provides crash data and thus a direct measure of safety risk. OTR assessments do not offer direct measures of crash risk, but do provide an accepted standard measure of fitness to drive, and expose both groups to the same driving challenges thus circumventing any effect of compensatory strategies (e.g., avoiding night driving) that can mask genuine driving deficits. High fidelity simulators are less naturalistic but can use a range of driving conditions and assess driving response to situations with high crash potential.
Studies were excluded if outcomes were measures of driving strategy 6 only (e.g., avoiding rush hour), as the focus of this study is the involuntary degradation of functional driving ability in PD (rather than voluntary driving behaviors). We also excluded studies assessing performance outside of a driving context (e.g., Stroop response time), given the inconsistent link between such neuropsychological assessments and actual road performance. 7 Driving outcomes Primary outcomes were (1) crashes (e.g., crash involvement [yes/no] or number of crashes), and (2) overall driving competence (e.g., test failure or overall performance ratings).
We examined only aggregate or overall driving competence outcomes, because separate analysis of all individual driving components that typically comprise overall outcome scores (e.g., lane deviation, road excursions) would produce excessive type I errors and multiple analyses varying in their sample sizes and methodologic characteristics. We excluded (1) absolute speed because its relationship with driving competence is complex and dependent on driving context 8 and (2) use of gears, route recall, or pedal (e.g., brake) pressure, as these were not considered to be direct measures of driving competence.
Information sources
PubMed, Embase, Transport Research International Documentation, CENTRAL, CINAHL Plus with Full Text, PsycINFO, and Web of Science databases were searched from database inception until January 25, 2018.
Search terms
Searches of database subject headings (where provided) and free text words of all fields were conducted to identify the largest possible pool of potentially eligible studies. PubMed search terms were as follows, with equivalent strings constructed for other databases: ("automobile driving" [ Glossary CI = confidence interval; HC = healthy control; OR = odds ratio; OTR = on-the-road; PD = Parkinson disease; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SMD = standardized mean difference; UPDRS-III = Unified Parkinson's Disease Rating Scale, Part III.
No language restrictions were imposed. Searches were filtered with the Cochrane sensitivity-maximizing human filter. The search strategy was augmented by hand searching of relevant reviews and included articles.
Study selection
After removal of duplicates, 2 independent reviewers (C.M., D.P.) screened titles/abstracts (stage 1), followed by full-text review of any resultant potentially eligible articles (stage 2). If multiple articles presented the same outcome data, only one article was retained (that with the clearest reporting or largest sample size), unless other articles also reported additional unique outcomes (in which case only unique outcomes were used). Ten corresponding authors of eligible articles were contacted across an 8-week period to clarify procedures or request additional data, with a single follow-up e-mail sent in the event of nonresponse. Six authors (see acknowledgment section) replied and provided query resolutions. Any disagreements at any stage of the selection process were resolved by discussion with a third reviewer (T.T.) to reach a final list of retained articles.
Quality of evidence
Two reviewers (C.M., D.P.) independently rated the quality of supporting evidence on an 18-item validity scale (appendix e-1, links.lww.com/WNL/A655) based on Cochrane criteria and PRISMA recommendations and adapted from our previous work 9 for the current topic. Criteria were scored as unmet if their endorsement could not be explicitly demonstrated (i.e., criteria were unmet or unreported).
Standard protocol approvals, registrations, and patient consents No additional ethical approval was required for this metaanalysis.
Data extraction
Extraction and coding of study data were performed by one reviewer (C.M.) on a standardized form 9 with 100% of extracted data checked for accuracy by one reviewer (T.T.). The following data were extracted: (1) sociodemographic variables; (2) for PD: mean disease duration (years), symptom severity, functional state (on/off) during driving/disease assessment, diagnostic criteria, cognitive impairment, usual treatment; (3) lifetime driving experience (e.g., years license held) and current driving exposure (e.g., miles driven per week); (4) assessment model (real-life, OTR, driving simulator); and (5) outcomes. Where study data allowed computation of multiple effect sizes (e.g., across repeated trials), all such data were extracted.
Several extraction decisions were made: (1) where experimental manipulations were used during driving assessment (k = 2), baseline data only were extracted; (2) for one research group reporting total and individual driving scores, we extracted the latter because of ambiguity in the former; (3) for one prospective study 10 that reported raw crash data and crash data adjusted for different group follow-up periods and other potential confounds, we included adjusted statistics only; (4) for one study reporting test outcome as safe/unsafe, we recoded this as pass/fail for consistency; and (5) a few studies reported median outcomes, which we used as an approximation of the mean. The effect of decisions 4 and 5 was examined in sensitivity analysis.
Effect size
For continuous outcomes, the standardized mean difference (SMD) for PD vs HCs was computed using Hedges g formula, where 0.20, 0.50, and 0.80 can be roughly translated as small, medium, and large effects. 11 For categorical outcomes (e.g., crash history, yes/no), odds ratios (ORs) were computed (log ORs were used in the meta-analysis and subsequently converted back to ORs).
Effect sizes were coded so that positive values (for both SMD and log OR) indicated driving impairment in PD (e.g., more driving errors, higher crash rate).
Meta-analysis
Group differences in driving outcomes were estimated using a random-effects model given anticipated heterogeneity in effect size. Robust variance estimation 12 was used to model dependency among multiple effect sizes from within a study (when total and subscore effect sizes were reported, we included only the former). Because the same patient groups were used across several studies (identified by contacting authors and examining article text/data), we also reran analysis including patient group as a second-order hierarchical variable to account for sample dependency. If both ORs and SMDs were reported for an outcome and they could be meaningfully combined (e.g., crash occurrence and number of crashes), we transformed the least reported effect size to the most common in line with Campbell Collaboration recommendations.
Meta-analysis was performed on data collapsed across reallife, OTR, and simulator models. Assessment model was also added as a dummy-coded moderator, and if significant, separate meta-analyses were performed for each model. Analyses were not performed if adjusted df < 4 (reflecting insufficient independent studies) because such model estimates are unreliable. 12 
Meta-regression
If moderate or greater inconsistency (I 2 > 50%
13
) in effect size emerged, meta-regression analyses were performed to identify potential sources of effect size variation.
The primary moderator was disease severity (symptom severity/disease duration), as increased neurodegeneration causes greater impairment. Secondary moderators consisted of medication dosage (L-dopa equivalent), study sex ratio, age, and lifetime driving experience.
If PD and HC groups differed on potential confounds of driving experience, age, and sex, which could explain group differences in driving outcomes, we reran analyses entering standardized difference scores on these variables as covariates. For real-life crash data, where miles driven cannot be experimentally fixed to be equivalent across groups, we included current driving exposure (e.g., mileage) differences over the assessed crash period as a covariate.
Publication bias
Funnel plots of mean study effect sizes against standard errors were examined for indicators of possible publication bias, with any asymmetry caused by a lack of small studies with small effects tested statistically.
14,15
Analysis software All analyses were performed using the metafor 16 and robumeta 17 packages in R.
Data availability
Data can be made available to qualified investigators on request to the corresponding author.
Results

Study selection and data characteristics Study inclusion
Database searches identified 3,962 unique hits, with initial screening of titles/abstracts identifying 226 potentially eligible articles, further reduced to 54 eligible articles following full text review (figure 1). Of these 54 articles, 50 provided sufficient quantitative data for meta-analysis consisting of a total n = 5,410 (n = 1,955 PD; n = 3,455 HC). The 50 articles represented 43 journal publications, 4 conference abstracts, 2 PhD theses, and 1 transport report. Detailed individual study characteristics are presented in table e-1 (links.lww.com/ WNL/A656) and summarized below.
Participant characteristics
Thirty-seven unique participant samples were identified as being used across the 50 studies (often with different driving models/outcomes) with an aggregate n = 4,149 (n = 1,576 PD, n = 2,573 HC). Mean (M) age (reported for k = 36 of 37 samples) was similar for PD (M = 66.6 years, SD = 4.7, range = 54-75) and HCs (M = 65.6 years, SD = 6.8, range = 48-77), although the mean proportion of males (k = 31) was higher for PD (M = 74%, SD = 17.6, range = 12-100) compared to HCs (M = 62%, SD = 18.1, range = 14-100).
Where lifetime driving experience had been reported (k = 24), people with PD and HCs were similar in mean years of driving experience (k = 15; PD M = 44.2 years, HC M = 42.9 years) and when other classifications (k = 9) were used, such as the proportion of participants with >10 years' driving experience. Current driving exposure (k = 24) was assessed in a variety of metrics with most studies reporting similar values for both groups, e.g., number of days driven per week (k = 8; PD M = 5.2, HC M = 5.5).
Samples were recruited from the following locations: United
, Finland (k = 1), the Netherlands (k = 1), Thailand (k = 1), and United Kingdom (k = 1).
PD severity and medication
Mean disease duration (reported for k = 22 of 37 samples) was 6.7 years (SD = 1.6, range = 3.5-10.9) with symptom severity assessed during the "on" A minimum level of cognitive functioning in PD for study inclusion was specified by 14 studies, with Mini-Mental State Examination score ≥24 being the most common criterion. The mean Mini-Mental State Examination score (k = 21) was 28.2. Driving assessments were administered during "on" states (k = 22), with 15 studies not reporting on/off state.
Assessment outcomes Real-life driving data
Fifteen studies provided naturalistic driving data, with 13 providing self-reported crash statistics for 2,143 (n = 873 PD, n = 1,270 HC) participants, and 2 studies providing speed and response times using in-car monitoring technology. Crash statistics were (1) the proportion of each group involved in a crash (k = 8), and (2) number of crashes (k = 5) experienced over a mean period of 3.0 years (SD = 2.5, range = 1-10 years). Crashes were typically treated as driving events causing injury or damage to the vehicle. Most assessments consisted of a generic self-report statement (e.g., "How many accidents have you been involved in over the past X years?"), with one study corroborating self-report with department of transport records. Scoring was performed by a professional driving instructor, k = 11, driving rehabilitation specialist, k = 8, or trained experimenter, k = 2 (4 studies used 2 types of assessor). Performance was evaluated during assessment (k = 12), by postassessment video review (k = 4), or both (k = 1). Driving tests were mostly 45 to 60 minutes in duration and performed in an instrumented vehicle in off-peak, daylight hours in good weather using a mixture of residential, suburban, urban, and highway roads.
Main driving outcomes were (1) test pass/failure (k = 8) and/or (2) overall performance score (k = 15). (Three studies 8, 19, 20 of 18 originally identified were excluded from analysis of overall test performance because they reported performance subscale scores used to compute overall scores in another included study. 21 ) Performance scores were typically computed by summing scores on a broad range of individual driving elements (e.g., lane deviation, speed control, maneuvers).
Driving simulator assessments
Twenty-five studies with a total n = 1,420 (PD = 628, HC = 792) assessed driving performance using a variety of simulators with real car or simulated cockpits. Sessions typically lasted 5 to 20 minutes (k = 12; M = 11 minutes), with multiple sessions sometimes used. Everyday driving situations were commonly reproduced using different road and traffic conditions involving simple to hazardous driving (e.g., cars turning out of side streets). Performance was scored by a driving instructor (e.g., traffic sign compliance) or automatically by the simulator (e.g., lane deviation).
Outcomes included (1) crash rate/number of crashes (k = 8), usually collisions with pedestrians, cars, and objects in challenging driving scenarios, and/or (2) performance scores (k = 22). Performance aspects frequently assessed included speed regulation, lane deviation, reaction time (e.g., to red lights), stop sign errors, etc. Most (k = 14) of the 22 test performance studies assessed performance on a relatively broad range of
Participant characteristics were similar across real-life, OTR, and simulator studies (see sections "participant characteristics" and "PD severity and medication" above), with the
Quality of supporting evidence
Study validity ratings (appendix e-1, links.lww.com/WNL/ A655) largely appeared to support sound methodologic practices, with driving assessed using well-established assessment protocols (96% of studies) and clearly defined performance measures (92%). Most studies reported similar group age (86%) and driving experience (64%). However, male/ female ratio was similar for only 46% of included studies, and thus we examined sex as a possible confounder (see section "confounders" below). Most studies used performance measures adjudged to be sufficiently broad to reflect overall competence (74%), but table e-1 (links.lww.com/WNL/ A656) shows that some simulator studies used highly specific, circumscribed measures (e.g., reaction time to red lights). The potential influence of these studies was accordingly examined in sensitivity analysis (see section "sensitivity analysis" below). Finally, limited information was provided for selection of controls (42%) and many studies recruited participants with PD from movement disorder clinics, and thus generalizability is difficult to ascertain. Regarding PD, movement clinics attract both complex referrals from neurologists and relatively noncomplex patients from the local community, and thus there appears to be no obvious reason why study patients would be unrepresentative of the wider PD community.
Rater agreement
Interrater agreement for final study selection was 97%, with 86% overall agreement on study validity items. All disagreements were resolved following discussion with a third reviewer.
Meta-analysis All outcome data
Meta-analysis of all outcome data (k = 50) indicated moderate 11 overall driving impairment in PD (figure 2) (SMD = 0.48, 95% confidence interval [CI] 0.35-0.62, p < 0.001). However, a moderating effect of assessment type revealed greater impairment for OTR (DSMD = 0.87, p < 0.001) and simulator (DSMD = 0.56, p = 0.007) assessments compared to real-life driving, and thus meta-analysis was conducted for each assessment method separately.
Real-life data
Eight studies reporting crash rates (PD M = 18.5%, HC M = 21.0%) were combined with 5 studies reporting mean crashes. Meta-analysis of the 13 studies (n = 2,143) revealed slightly lower odds of crash involvement for those with PD compared to HCs (figure 3), but this did not reach significance (OR = 0.84, 95% CI 0.57-1.23, p = 0.38). High inconsistency in the magnitude of these effects was observed (I 2 = 71%, τ 2 = 0.40).
OTR driving tests
Driving test failure rates (k = 8; n = 821) and test performance scores (k = 15; n = 1,865) were analyzed separately, as test failure rate in particular represents an easily interpretable and meaningful index of driving competence. Analysis revealed the odds of test failure were slightly more than 6 times greater for patients with PD (figure 4) (OR = 6.16, 95% CI 3.79-10.03, p < 0.001), with a mean failure rate of 46.5% in participants with PD and 12.2% in HCs. Low heterogeneity was observed (I 2 = 24%, τ 2 = 0.11), with all studies finding higher failure rates in PD. Analysis of test performance scores (figure 5) also found poorer performance in PD (SMD = 0.67, 95% CI 0.53-0.80, p < 0.001), suggesting moderate to high impairment. 11 All studies indicated greater driving impairment in PD, but with variation in the magnitude of impairment (I 2 = 62%, τ 2 = 0.07).
Driving simulators
Crash data (k = 8; n = 598) and overall simulator performance scores (k = 22; n = 1,318) were analyzed separately, so that comparisons of crash rates across real-life (see section "real-life driving data") and simulator models could be made. 
Publication bias
Neither funnel plots nor statistical tests (p = 0.27-0.99) indicated effect size asymmetry for any outcomes, suggesting little detectable evidence of publication bias.
Meta-regression
Because primary moderator data were only reported by approximately half of the included studies, meta-regression was performed for each moderator on the whole dataset (pooled across assessment models) to maximize power, with assessment model included as a covariate to control for its impact on effect size. SMD (transformed and untransformed) was used as the effect size, as this was the predominant statistic reported.
Meta-regression found group differences in driving performance to be unaffected by primary moderators of disease duration (k = 27; p = 0.29) and symptom severity (Hoehn and Yahr: k = 29; p = 0.36; UPDRS-III: k = 24; p = 0.21), or secondary moderators of age (k = 44; p = 0.39), sex (k = 38; p = 0.38), L-dopa equivalent dosage (k = 20; p = 0.14), and years of driving experience (k = 16; p = 0.31).
Confounders
To control for the higher proportion of males in the PD samples, all analyses were rerun entering group differences in male/female proportion as a covariate but revealed little change in effect size (maximum change: SMD = 0.01, OR = 0.37). For real-life crash data, we were not able to enter driving exposure (section "meta-regression") over the assessed crash period as a covariate because of limited studies and the variety of metrics used (e.g., mileage, trip frequency). Instead, we reran meta-analysis of real-life crash data (section "real-life data") including 6 studies (n = 943) from the original 13 that reported driving exposure in PD as matching or exceeding that of HCs. An identical effect size of OR = 0.84 was found, demonstrating that lack of differences in self-reported crash rate was unlikely to be attributable to reduced driving exposure in PD.
Sensitivity analysis
Recomputing meta-analysis estimates after omitting studies in which (1) extraction decisions were made (section "data extraction"), (2) highly circumscribed simulator outcomes (section "driving simulator assessments") were used, and (3) SMDs were transformed to ORs and vice versa (sections "all outcome data" and "real-life data"), resulted in no substantive changes in effect size (maximum change: SMD = 0.05, OR = 0.13). Finally, including patient group as a second-order hierarchical variable (section "meta-analysis") resulted in negligible effect size changes, with the possible exception of overall performance scores in simulator studies, which saw a reduction from SMD = 0.50 to SMD = 0.30.
Missing studies
Four driving simulator studies of varying sample sizes (n = 9-53), described in conference abstracts by the same author (references e-51 to e-54, links.lww.com/WNL/ A656), were excluded because of insufficient outcome data, but reported results broadly consistent with analyzed data suggesting little evidence of bias from their omission.
Discussion
Meta-analysis of 50 studies totaling 5,410 participants provided clear evidence of driving impairment in OTR and driving simulator assessments, but found no evidence of increased risk of real-life crash involvement as assessed by self-report. More specifically: (1) in OTR tests, the odds of driving-test failure were more than 6 times higher for participants with PD compared to HCs, and overall test performance scores indicated moderate to strong impairment (SMD = 0.67); (2) in driving simulator assessments, the odds of crash involvement were more than 2.5 times higher in PD, and overall driving performance scores indicated moderate impairment (SMD = 0.50); (3) while considerable heterogeneity in the magnitude of performance degradation was generally observed, direction of effects in OTR and simulator assessments consistently indicated poorer performance; and (4) no evidence was found that the degree of driving impairment was moderated by disease severity, disease duration, or medication dosage.
Meta-analysis of OTR and simulator data provided convincing evidence of impaired driving competency in PD, which could not be attributed to group differences in age or sex. Because OTR assessments were largely based on established, standardized driving tests used to determine licensure and fitness to drive, these results suggest that key skills required for typical everyday driving challenges are compromised in PD. While simulator assessments may be less representative of real-life driving, especially when a single, molecular driving assessment is used (e.g., reaction time to a red light), a consistent pattern of impairment to OTR assessments in independent studies was nevertheless observed. This would seem to suggest that, when confronted with equivalent driving challenges in real life, those with PD are likely to perform more poorly. Furthermore, driving tests were conducted during optimal conditions (e.g., daylight, good weather, optimal medication states), suggesting further performance degradation is likely during more difficult conditions when already compromised cognitive, motor, and perceptual capacities are further challenged. 22 It is also noteworthy that average Hoehn and Yahr severity stage ranged from 1 to 3, suggesting substantive driving impairment occurs even at the early mild to moderate disability levels, when the patient is usually considered to be fully independent in all activities of daily living.
However, despite strong evidence of impaired ability, PD was not associated with inflated real-life crash risk, based on selfreport data from more than 2,100 participants. This finding could not be attributed simply to reduced driving exposure in PD (e.g., fewer trips or miles covered). One possible explanation for the lack of increased crash risk is that people with PD self-regulate their driving behavior in a number of ways. They may use compensatory strategies (e.g., driving more slowly, avoiding risky maneuvers such as turning across traffic flow, using familiar roads) that minimize challenges to their impairments. 10, 23 In addition, evidence suggests that drivers with PD with the most severe driving deficits, who are likely to be those with the highest crash vulnerability, may simply elect to discontinue driving altogether. 10, 18 A second possibility is that the driving deficits observed in PD simply do not contribute substantially to crash risk; rather, established factors such as distracted driving (e.g., cell phone use), speeding, alcohol, and driving attitude could be the primary risk factors for crashes.
Given that PD is a progressive disease, the lack of relationship between driving impairment and disease duration or severity based on 32 studies is somewhat surprising. This finding suggests that driving impairment may occur relatively early on in the disease state with little evidence of further deterioration. Nevertheless, several caveats should be applied to this interpretation. First, patient samples were generally restricted to those with a Hoehn and Yahr stage of 1-3, and it may be that substantial deterioration is seen only at stage 4 (severely disabling), when many patients with PD may elect to discontinue driving. Second, disease severity measures used, typically Hoehn and Yahr staging and UPDRS-III, were based on motor dysfunction. However, it is well recognized that severity of nonmotor symptoms such as cognitive and visual dysfunction in PD are key predictors of poor driving performance. 10, 18 Finally, standardized road tests may fail to detect motor-based impairment in driving as they do not include hazardous circumstances that require immediate motor response. Nevertheless, real-life and simulator driving do incorporate such hazards, and so any existing relationship might still be expected to emerge in these data. 22 Collectively, there appears to be no persuasive evidence that driving progressively degrades with increasing severity in motor dysfunction up to Hoehn and Yahr stage 3, but it would be unwise to dismiss this possibility, or a role of nonmotor symptoms, without further primary studies.
There is no persuasive evidence that drivers with PD show an increased real-life crash risk based on currently available selfreport data. While the reliability of such data is uncertain, they do little to advance arguments for immediate legislative change in relicensing or current clinician recommendations for those with PD, pending availability of more objective measures. People with PD often self-regulate their driving to limit safety risk, 3, 10 and the most effective reassessment is likely to be that performed on an individual case-by-case basis rather than driven by diagnosis. 24 At the same time, it is evident that PD is associated with some degree of operational deficit in driving ability, even if there is currently limited evidence that safety is compromised. Awareness of this in assessors may help the development of targeted interventions to tackle these deficits, improving competency when more challenging driving situations are encountered. PD deficits may be similar to those of the older driver, and may benefit from specific areas of retraining highlighted by assessment, such as awareness of road positioning and speed regulation. 25 Limitations of the study should be noted. First, real-life crash data were based on self-report, and fear of license revocation or encouraging negative perceptions may cause drivers with PD to underreport their crash involvement. 26 Inaccuracy of reporting may also be a product of a diminished higher-order ability to self-reflect on performance deficits exhibited by some patients with PD, 27 and efforts to develop accurate assessment of such metacognitive deficits may also be an important factor in determining driving capacity. It is of interest that crash statistics from the one primary study that used state records 3, 10 were only negligibly different from overall metaanalytic summary estimates that were otherwise based on selfreport. Furthermore, a recent study found "substantial" agreement between self-reported and state-recorded crashes in 2,000 older adults 28 who may be susceptible to similar bias. Nevertheless, it would be unwise to draw firm conclusions without further corroborating evidence. Second, PD study samples in OTR and simulator studies may be biased toward more confident drivers less fearful of evaluation, 26 which would suggest driving ability might even be further impaired in the wider PD population. Third, while we found no evidence that the lack of inflated real-life crash risk in PD might be attributable to reduced driving exposure, limited available information and the variety of different metrics used (e.g., trips, monthly mileage) restricted analytical power of our analysis and it is unwise to discount this as a possible explanatory factor. Similarly, factors such as daytime sleepiness/ sudden sleep onset, nonuse of medication, visuospatial deficits, and severe global cognitive impairment (beyond the level commonly specified by study entry criteria) may also contribute to driving impairment but could not be examined because of inadequate data for meta-analysis. Fourth, while meta-analytic summary data provide important information on "average" impairment, PD is a heterogeneous condition, and thorough assessment of each individual case is essential to reliably determine fitness to drive.
Further research examining real-life driving based on largesample "objective" crash statistics such as transport department records and insurance data, or empirical naturalistic driving data such as computerized multimodal quantitative assessments of driver behavior in the driver's own vehicle, 29 are needed to corroborate self-report findings. Although such databases are not currently readily accessible, future availability would increase confidence in the current findings and potentially highlight situations in which crash vulnerability might be increased. Insights into whether overall driving impairment is primarily driven by selective impairment in individual motor, cognitive, or visual deficits or for specific driving situations would also be gained by large-sample OTR and simulator studies with carefully specified a priori comparison of outcomes. Such research could help target areas of driving impairment for retraining.
In summary, meta-analysis of a total of 5,410 participants across 50 studies revealed persuasive evidence of driving performance deficits in those with PD. Participants with PD had an odds of on-the-test failure more than 6 times higher than controls, had more crashes in driving simulators, and were rated more poorly on overall driving performance. However, there is currently no evidence of an increased crash risk in real-life driving based on self-report data, although corroborative objective indices are required. Driving is an important public safety issue, and ensuring fitness to drive is paramount to minimizing injuries and fatalities that occur on the road. However, these results do little to support mandated periodic driving reassessment for patients with PD based on currently available evidence, and encourage thorough individualized assessment as the most appropriate method for determining fitness to drive.
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